https://www.selleckchem.com/pr....oducts/p5091-p005091
(3) Results We recruited 117 FPs and 593 of their patients. In the intention-to-treat analysis, the between-group difference for the mean MAI score change after a 6-month follow-up was -2.42 (95% CI from -4.27 to -0.59) and, between baseline and a 12-month follow-up was -3.40 (95% CI from -5.45 to -1.34). There were no significant differences in any other secondary outcomes. (4) Conclusions The MULTIPAP intervention improved medication appropriateness sustainably over the follow-up time. The small magnitude of the effect, however,
Like
Comment
Share
